BioSpace News Archive

Drug Development

EpicentRx “BETA-PRIME” Phase 1 Study Progresses After Demonstrating Good Safety and Tolerability

EpicentRx Inc., a leading-edge immunotherapy company using groundbreaking science to treat cancer and multiple inflammatory-driven diseases, today announced the initiation of the next stage of its Phase 1 trial, BETA-PRIME, with AdAPT-001, a TGF-beta (TGFß) trap-enhanced cancer targeting adenovirus.

April 21, 2022
·
2 min read
Biotech Beach

Qpex Biopharma Announces Presentation of Clinical Data for Ultra-Broad Spectrum β-lactamase Inhibitor Xeruborbactam and the Lipopeptide QPX9003 at ECCMID 2022 Meeting

Qpex Biopharma, Inc. today announced the company will present new clinical data for their β-lactamase inhibitor xeruborbactam (formerly QPX7728) and synthetic lipopeptide QPX9003 at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) being held on April 23-26, 2022.

April 21, 2022
·
4 min read
Drug Development

Aldeyra Therapeutics Announces Presentation of Clinical Data at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Aldeyra Therapeutics Announces Presentation of Clinical Data at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting.

April 21, 2022
·
7 min read
BioMidwest

ENDRA Life Sciences Raises $8.7 Million in Gross Proceeds Through its At-The-Market Facility

ENDRA Life Sciences Inc. announces that the Company has raised $8.7 million in gross proceeds year-to-date from the sale of common stock through its at-the-market (ATM) equity facility.

April 21, 2022
·
4 min read
Business

Truvian Sciences Appoints Top Industry Veterans to its Leadership Team as it Prepares to Commercialize its Automated Benchtop Blood Testing System

Truvian Sciences (“Truvian”) today announced four executive appointments that bring expanded industry and commercialization experience to the company as it advances toward submitting for U.S. Food and Drug Administration (FDA) clearance of its automated benchtop blood testing system.

April 21, 2022
·
3 min read
Biotech Bay

Purigen Launches Ionic® Cells to Pure DNA Kit for White Blood Cell and Peripheral Blood Mononuclear Cell Control Samples

Purigen Launches Ionic ® Cells to Pure DNA Kit for White Blood Cell and Peripheral Blood Mononuclear Cell Control Samples.

April 21, 2022
·
3 min read
Biotech Bay

Mendel Raises $40 Million Series B Round to Expand its Team and Grow Product Offering

Mendel today announced it has raised $40 million in Series B funding round led by Oak HC/FT.

April 21, 2022
·
3 min read
Business

Octant Raises $80 Million Series B Round to Support Expansion of Next-Generation Drug Discovery Platform, Announces Collaboration with Bristol Myers Squibb and Key Appointments

Series B Round led by Catalio Capital Management Brings Total Capital Raised to Date to $115 Million.

April 21, 2022
·
6 min read
Business

Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software

Simulations Plus, Inc. today announced a new funded collaboration with a large pharmaceutical company to expand and validate the mechanistic in vitro dissolution models for intravitreal injectable formulations within the DDDPlus™ software.

April 21, 2022
·
3 min read
Biotech Bay

PacBio transforms access to the epigenome and streamlines workflows

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced the release of a transformative capability to detect DNA methylation using the Sequel IIe and Sequel II Systems.

April 21, 2022
·
6 min read